Albemarle (ALB)
NYSE: ALB · Specialty Chemicals · Charlotte, NC
Our rating: Neutral
Call changed from Cautious to Neutral at $98.37, moderate conviction, November 5, 2026.
Breaks if: The Neutral call would shift Cautious if reported free cash flow falls below $350M in any two consecutive quarterly filings, signaling that the commodity downcycle is biting deeper into cash generation than the current figures suggest. It would shift Positive if revenue returns to year-over-year growth of 10% or more across two consecutive quarters and net income turns positive in that same window, indicating a genuine lithium price recovery feeding through to the bottom line — neither condition is met today.
Key figures
| Market value | $9.4B |
|---|---|
| Revenue, last 12 months | $6.2B |
| Net income, last 12 months | $682M |
| Free cash flow, last 12 months | $1.4B |
| Price to earnings | 13.8× |
| Free cash flow yield | 15.4% |
| Dividend yield | 2.0% |
| Operating margin | 10.0% |
| Return on equity | 6.6% |
| Beta to the S&P 500 | 1.50 |
| Volatility, annualized | 57.4% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $1.6B | 18.8% | $2.15 | $325M |
| June 30, 2026 | $1.7B | 31.1% | $3.52 | $638M |
| March 31, 2026 | $1.4B | 32.7% | $2.34 | $248M |
| December 31, 2025 | $1.4B | 15.9% | $-3.88 | $233M |
| September 30, 2025 | $1.3B | −3.5% | $-1.72 | $223M |
| June 30, 2025 | $1.3B | −7.0% | $-0.16 | −$129M |
| March 31, 2025 | $1.1B | −20.9% | $0.00 | $365M |
| December 31, 2024 | $1.2B | −47.7% | $0.29 | −$347M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $1.78B: Claude 32%, Gemini 40%, Mistral 45%
- Diluted earnings per share are above zero: Claude 85%, Gemini 95%, Mistral 90%
- Free cash flow for the quarter is at least $0.23B: Claude 58%, Gemini 85%, Mistral 80%
13 ledger entries and 67 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.